is semaglutide a glp one Comparing Ozempic, Wegovy and Other GLP-1 Drugs Semaglutide (GLP-1) for Medical Weight

doi: 10.1016/j.soard.2010.10.014 111

Clinical trials of semaglutide show mixed effects on blood pressure: some patients experience modest reductions, while others see minimal change or slight increases, particularly in the first weeks of treatment

The contraindications for semaglutide include a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), known hypersensitivity to semaglutide or any product components, and for Wegovy specifically, pregnancy

Dans un essai men en double aveugle de 68 semaines, dont les rsultats ont t dcrits par l'Agence europenne du mdicament, 611 patients souffrant d'obsit ou de surpoids ont reu le smaglutide ou un placebo